Latest Breaking News On - அமர் கிஷன் - Page 1 : comparemela.com

Multimodality therapy critical for treating more aggressive prostate cancers Findings Men with high-risk prostate cancer with at least one additional aggressive feature have the best outcomes when treated with multiple healthcare disciplines, known as multimodality care, according to a UCLA study led by Dr. Amar Kishan, assistant professor of radiation oncology at the David Geffen School of Medicine at UCLA and a researcher at the UCLA Jonsson Comprehensive Cancer Center. The study found no difference in prostate cancer-specific deaths across treatment modalities when patients received guideline-concordant multimodality therapy, which in this case was inclusion of hormone therapy for men receiving radiation and a low-bar for postoperative radiation in men undergoing surgery. The research team did however, find significant differences in deaths when guideline-concordant multimodality care was not delivered. Those treated with external beam radiotherapy or external beam radiotherapy

Amar kishanEmily hendersonDavid geffen school of medicineJonsson comprehensive cancer centerDavid geffen schoolComprehensive cancerஅமர் கிஷன்எமிலி ஹென்டர்சன்டேவிட் கெஃப்ஃபெந் பள்ளி ஆஃப் மருந்துஜான்சன் விரிவான புற்றுநோய் மையம்டேவிட் கெஃப்ஃபெந் பள்ளிவிரிவான புற்றுநோய்